Healthy
Conditions
Brief summary
The purpose of this study is to investigate how gut hormones and brain areas respond differently to gastric distention, tasteless calories, or palatable food and how this alters appetite.
Interventions
OTHERFunctional Magnetic Resonance Imaging (pCASL-MRI)
MRI's will be performed at multiple points on each visit day.
OTHERIntragastric Balloon
Intragastric Balloon will be placed during Visit 2 study day and inflated to maximum tolerated volume. Patient will then be scanned in the MRI.
OTHERElemental Meal
Patient will ingest the tasteless elemental meal until their maximum level of fullness. Once full, the patient will be scanned in the MRI.
OTHERHedonic Meal
Patient will ingest meal of their choice from a local food delivery service and eat until they reach their maximum level of fullness. Once full, the patient will be scanned in the MRI
Sponsors
Mayo Clinic
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
21 Years to 50 Years
Healthy volunteers
Yes
Inclusion criteria
* BMI 18-25 kg/m\^2. * Weight stable for 3 months prior to study entry. * For females: study days will be scheduled during the follicular phase of their menstrual cycle (i.e., the first 13 days (about 2 weeks) of the cycle). * Able to provide written informed consent prior to any study procedures and be willing and able to follow study procedures.. * Ability to perform light to moderate physical activity.
Exclusion criteria
* Any contraindication for MRI scanning. * Any history of childhood (\> 95th percentile) or adult obesity (BMI \>30 kg/m\^2). * Claustrophobia. * High intensity training or physical activity. * Any contraindication for intragastric balloon insertion. * Any allergies to the study meals. * Any history of eating disorder. * Any substance abuse disorder (including alcohol and tobacco). * Any history of psychiatric disorders. * Any cardiovascular, endocrine, pulmonary, neurological, or gastrointestinal comorbidities. * Pregnancy or nursing. * Any history of bariatric surgery or endoscopic bariatric procedure. * Use of any medication or supplement that alters appetite. * Patient has a known history of any condition or factor judged by the investigator to prevent participation in the study or which might hinder study adherence.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Difference in Cerebral Blood Flow related to hypothalamus | 1 month | The mean difference in cerebral blood flow (CBF) at fullness (satiation) and return to hunger (satiety) to the hypothalamic area. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Cerebral Blood Flow between three stimuli | 1 month | The mean difference in cerebral blood flow (CBF) between the 3 different stimuli. |
| Hormone level | 1 month | Differences in hormones levels (ghrelin, GLP-1, CCK, PYY, leptin, insulin, GIP, amylin) at each of the stages (I.e., baseline, fullness, maximal fullness) after the three different stimulations. These hormones will be compared before and after the same stimulation days. The hormone measurements on stimulation days will also be compared to each other. |
| comparison of calories | 1 month | Correlation the caloric consumption to fullness, maximal fullness with degree of cerebral blood flow(CBF) change on PASL MRI. |
| calorie corellation to hormones | 1 month | Correlation the caloric consumption to fullness, maximal fullness with changes in the hormonal levels (ghrelin, GLP-1, CCK, PYY, leptin, insulin, GIP, amylin). |
| Cerebral Bloodflow related in multiple brain areas | 1 month | The mean difference in cerebral blood flow (CBF) at fullness (satiation) and return to hunger (satiety) to the other brain areas related to food intake regulation. |
| Time differences in stimuli | 1 month | Differences in time to next meal after maximal fullness after the three different stimulations. |
| Caloric consumption differences in stimuli | 1 month | Differences in the caloric consumption after maximal fullness after the three different stimulations. |
| FitBit measured Physical Activity | 1 month | Measurement of daily physical activity during free-living conditions measured through the use of FitBit tracker over the duration of the study. |
| hormone level comparison | 1 month | Differences in the hormonal levels (ghrelin, GLP-1, CCK, PYY, leptin, insulin, GIP, amylin) between fullness and hunger after the three different stimulations. These hormones will be compared before and after the same stimulation days. The hormone measurements on stimulation days will also be compared to each other. |
Countries
United States
Contacts
Primary ContactMegan Schaefer
Outcome results
None listed